Published in J Neurol Neurosurg Psychiatry on June 01, 1985
Current concepts in immunology: Regulation of the immune response--inducer and suppressor T-lymphocyte subsets in human beings. N Engl J Med (1980) 4.80
Quantal components of end-plate potentials in the myasthenic syndrome. Ann N Y Acad Sci (1971) 2.73
Heterogeneity of human T4+ inducer T cells defined by a monoclonal antibody that delineates two functional subpopulations. J Immunol (1982) 2.60
Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet (1981) 2.36
Functional analysis of human T cell subsets defined by monoclonal antibodies. IV. Induction of suppressor cells within the OKT4+ population. J Exp Med (1981) 2.35
Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. J Clin Invest (1980) 2.06
Deficit of suppressor T cells in active multiple sclerosis. Lancet (1980) 1.83
Circadian variation of lymphocyte subpopulations: a study with monoclonal antibodies. Br Med J (Clin Res Ed) (1983) 1.72
Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc Natl Acad Sci U S A (1983) 1.71
Functional analysis of human T cell subsets defined by monoclonal antibodies. V. Suppressor cells within the activated OKT4+ population belong to a distinct subset. J Immunol (1982) 1.63
Evaluation of T cell subsets in myasthenia gravis using anti-T cell monoclonal antibodies. Clin Exp Immunol (1981) 1.42
Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse. J Physiol (1983) 1.33
Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome. Neurology (1984) 1.29
Autoimmunity in the Lambert-Eaton myasthenic syndrome. Muscle Nerve (1982) 1.28
Diurnal variation of lymphocyte subsets identified by monoclonal antibodies. Br Med J (Clin Res Ed) (1983) 1.18
Lymphocyte subpopulations and suppressor cell activity in acute polyradiculoneuritis (Guillain-Barré syndrome). Clin Exp Immunol (1983) 1.17
Lymphocyte subpopulations in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry (1983) 1.16
Peripheral blood lymphocyte sub-populations and multiple sclerosis. J Neuroimmunol (1984) 1.13
Analysis of T cell subsets in Graves' disease: alterations associated with carbimazole. Br Med J (Clin Res Ed) (1984) 1.08
T-cell subset analysis of cryopreserved human peripheral blood mononuclear cells. Immunol Lett (1983) 0.89
Passive transfer of Lambert-Eaton myasthenic syndrome in mice: decreased rates of resting and evoked release of acetylcholine from skeletal muscle. J Neurochem (1984) 0.85
Cholinergic dysautonomia and Eaton-Lambert syndrome. Neurology (1979) 0.85
Monoclonal antibody analysis of blood T-cell subsets in myasthenia gravis. Ann Neurol (1982) 0.81
An analysis of host T-cell subsets based on Lyt antigenic markers during the development of spontaneous C3H mammary carcinomas. Cell Immunol (1984) 0.79
Calcitriol for congenital osteopetrosis. N Engl J Med (1984) 0.77
Editorial retrospective. Human lymphocyte subpopulations in metastatic neoplasia--six years later. N Engl J Med (1983) 0.77
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med (2001) 3.26
The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain (1988) 2.73
Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet (1981) 2.36
Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain (1980) 2.36
Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome) Lancet (1991) 2.28
Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol (1997) 2.17
Prenatal onset spinal muscular atrophy. Eur J Paediatr Neurol (1999) 2.15
Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry (1985) 2.11
Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis. Brain (1990) 2.00
Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen. Lancet (1995) 1.94
Does computed tomography have a role in the evaluation of complicated acute bacterial meningitis in childhood? Dev Med Child Neurol (1992) 1.79
Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles. Clin Exp Immunol (1982) 1.78
Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line. Nature (1985) 1.76
Infection of mouse liver by human adenovirus type 5. J Gen Virol (1978) 1.74
Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain (1997) 1.73
Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc Natl Acad Sci U S A (1983) 1.71
Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Neurology (1978) 1.71
Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release. Lancet (1994) 1.69
Creutzfeldt-Jakob disease after administration of human growth hormone. Lancet (1985) 1.61
Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. J Neurol Sci (1997) 1.56
Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis. Ann Neurol (1997) 1.50
An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry (1995) 1.49
Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients. J Neurol Neurosurg Psychiatry (1991) 1.49
Bladder dysfunction in Duchenne muscular dystrophy. Arch Dis Child (2003) 1.47
Strength-duration properties of peripheral nerve in acquired neuromyotonia. Muscle Nerve (1999) 1.46
Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet (1984) 1.43
Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. Neurology (1992) 1.41
A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group. Neurology (1998) 1.40
Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study. Ann Neurol (1987) 1.38
Mutations in different functional domains of the human muscle acetylcholine receptor alpha subunit in patients with the slow-channel congenital myasthenic syndrome. Hum Mol Genet (1997) 1.33
Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse. J Physiol (1983) 1.33
Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset. Clin Exp Immunol (1982) 1.32
Abnormal respiration and sudden death during sleep in multiple system atrophy with autonomic failure. Neurology (1990) 1.31
Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome. Neurology (1984) 1.29
Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis. Clin Exp Immunol (2003) 1.28
Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer. J Neurol Neurosurg Psychiatry (2001) 1.25
Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis. Ann Neurol (2001) 1.25
Myasthenia gravis: population differences in disease expression and acetylcholine receptor antibody titers between Chinese and Caucasians. Neurology (1987) 1.24
Deletion 9p and sex reversal. J Med Genet (1993) 1.23
Congenital myasthenic syndromes in childhood: diagnostic and management challenges. J Neuroimmunol (2008) 1.22
Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells. Ann Neurol (1990) 1.22
Spontaneous neutralising antibodies to interferon--alpha and interleukin-12 in thymoma-associated autoimmune disease. Lancet (1997) 1.22
Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity. Lancet (1986) 1.20
Long mutant dystrophins and variable phenotypes: evasion of nonsense-mediated decay? Hum Genet (2001) 1.19
A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis. J Clin Invest (1988) 1.19
Respiratory involvement in multiple sclerosis. Brain (1992) 1.18
Myasthenic and nonmyasthenic thymoma. An expansion of a minor cortical epithelial cell subset? Am J Pathol (1987) 1.18
Congenital myopathies--clinical features and frequency of individual subtypes diagnosed over a 5-year period in the United Kingdom. Neuromuscul Disord (2013) 1.17
Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology. Neurology (1981) 1.17
The human muscle nicotinic acetylcholine receptor alpha-subunit exist as two isoforms: a novel exon. EMBO J (1990) 1.15
Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma. Neurology (1990) 1.15
Primary structure of the human muscle acetylcholine receptor. cDNA cloning of the gamma and epsilon subunits. Eur J Biochem (1993) 1.14
The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse. J Physiol (1987) 1.14
Rapsyn mutations in hereditary myasthenia: distinct early- and late-onset phenotypes. Neurology (2003) 1.13
Intravenous immunoglobulin in neurological disease: a specialist review. J Neurol Neurosurg Psychiatry (2002) 1.13
Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma. Lancet (1999) 1.13
Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder. Trends Neurosci (1989) 1.12
In-vitro synthesis of anti-acetylcholine-receptor antibody by thymic lymphocytes in myasthenia gravis. Lancet (1978) 1.12
Microenvironments in the normal thymus and the thymus in myasthenia gravis. Am J Pathol (1985) 1.12
Adenovirus antigens: a model system in mice for subunit vaccination. J Gen Virol (1974) 1.11
Acetylcholine receptors and end-plate electrophysiology in myasthenia gravis. Brain (1978) 1.11
Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene. Neurology (2005) 1.10
Distinct phenotypes of congenital acetylcholine receptor deficiency. Neuromuscul Disord (2004) 1.08
Purification of anti-acetylcholine receptor antibody from patients with myasthenia gravis. J Immunol Methods (1982) 1.08
Long-term effects of repeated plasma exchange in myasthenia gravis. Lancet (1979) 1.07
Natural history of Ullrich congenital muscular dystrophy. Neurology (2009) 1.07
Treatment with oral 4-aminopyridine in disorders of neuromuscular transmission. Neurology (1981) 1.06
Greatly increased autoantibody production in myasthenia gravis by thymocyte suspensions prepared with proteolytic enzymes. Clin Exp Immunol (1983) 1.06
Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes. Neurology (2002) 1.04
Interfamilial phenotypic heterogeneity in SMARD1. Neuromuscul Disord (2009) 1.03
Lambert-Eaton myasthenic syndrome IgG depletes presynaptic membrane active zone particles by antigenic modulation. Ann Neurol (1988) 1.03
Thymus dependence of the antibody response to tetanus toxoid in mice. Clin Exp Immunol (1975) 1.03
Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases. Muscle Nerve (1981) 1.03
Immunohistological studies of the thymus in myasthenia gravis. Correlation with clinical state and thymocyte culture responses. J Neuroimmunol (1982) 1.03
Thymus cells in myasthenia gravis selectively enhance production of anti-acetylcholine-receptor antibody by autologous blood lymphocytes. N Engl J Med (1981) 1.02
Acetylcholine receptor delta subunit mutations underlie a fast-channel myasthenic syndrome and arthrogryposis multiplex congenita. J Clin Invest (2001) 1.02
Lambert-Eaton myasthenic syndrome: I. Early morphological effects of IgG on the presynaptic membrane active zones. Ann Neurol (1987) 1.02
Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma x glioma cell line. J Physiol (1990) 1.02
Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function. J Clin Invest (1996) 1.01
Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome. Neurology (1996) 1.01
Increased frequency of IgG heavy chain marker Glm(2) and of HLA-B8 in Lambert-Eaton myasthenic syndrome with and without associated lung carcinoma. Hum Immunol (1985) 1.01
Mycoplasma pneumoniae infection and neurological disease. Arch Dis Child (1993) 1.00
Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. Ann Neurol (1991) 1.00
Critical role for the Val/Gly86 HLA-DR beta dimorphism in autoantigen presentation to human T cells. Proc Natl Acad Sci U S A (1991) 1.00
alpha-Bungarotoxin and anti-acetylcholine receptor antibody binding to the human acetylcholine receptor. Adv Cytopharmacol (1979) 1.00
Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes. J Clin Invest (1994) 1.00
Further evidence for dominant inheritance at the chromosome 15q11-13 locus in familial Angelman syndrome. Am J Med Genet (1992) 0.99
The respiratory system in muscular dystrophy. Br Med Bull (1980) 0.98
Lambert-Eaton myasthenic syndrome: electrophysiological evidence for a humoral factor. Muscle Nerve (1982) 0.98
Immunoglobulin M receptors on memory cells of immunoglobulin G antibody-forming cell clones. Eur J Immunol (1976) 0.98
Magnetic resonance imaging of inflammatory and demyelinating white-matter diseases of childhood. Dev Med Child Neurol (1990) 0.98
Acetylcholine receptor antibody and clinical response to thymectomy in myasthenia gravis. Neurology (1983) 0.98
Asymptomatic maternal myasthenia as a cause of the Pena-Shokeir phenotype. Am J Med Genet (2000) 0.97
Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia. Arch Neurol (2000) 0.96
Antibody heterogeneity and specificity in myasthenia gravis. Ann N Y Acad Sci (1987) 0.96
Action of Lambert-Eaton myasthenic syndrome IgG at mouse motor nerve terminals. Ann Neurol (1985) 0.96